Aristotle Atlantic Partners LLC Has $10.83 Million Stock Holdings in Cigna Group $CI

Aristotle Atlantic Partners LLC trimmed its position in Cigna Group (NYSE:CI) by 4.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,354 shares of the health services provider’s stock after selling 1,790 shares during the quarter. Aristotle Atlantic Partners LLC’s holdings in Cigna Group were worth $10,831,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in CI. Brighton Jones LLC boosted its stake in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after buying an additional 109 shares during the period. NewEdge Advisors LLC boosted its stake in shares of Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina boosted its stake in shares of Cigna Group by 16.6% in the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. bought a new stake in shares of Cigna Group in the second quarter valued at approximately $163,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

NYSE:CI opened at $285.27 on Thursday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The firm has a market capitalization of $75.46 billion, a PE ratio of 12.09, a price-to-earnings-growth ratio of 1.13 and a beta of 0.28. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock’s 50-day simple moving average is $283.63 and its 200 day simple moving average is $278.31.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the prior year, the company earned $6.74 EPS. Cigna Group’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Insiders Place Their Bets

In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently commented on CI. Wolfe Research restated an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a research report on Tuesday. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Morgan Stanley boosted their target price on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research report on Friday, May 1st. Finally, Piper Sandler dropped their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $338.30.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.